ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo
SOLANA BEACH, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced installation and completion of an initial procedure with both the ClearPoint Prism Neuro Laser Therapy System and the ClearPoint Neuro Navigation System by Dr. Jonathan Riley and team at Kaleida Health in Buffalo, New York.
Related news for (CLPT)
- Dawn of Disruption: Ad Tech M&A Frenzy and Venue Visions Light Up Tuesday’s Tape
- clearpoint neuro to announce third quarter 2024 results november 7, 2024
- clearpoint neuro announces early repayment of $10 million note
- ClearPoint Neuro tillkännager sin första EU MDR-certifiering och godkännande att skicka produkter till Europa